Introduction
Incorporated in October 1965, Transpek Industry Limited (TIL) initially ventured into the production of acrylic plastic sheets at its plant in Atladra, Gujarat. However, it transitioned to chemical manufacturing in 1969, marking the beginning of its journey in the chemical industry.
Transpek Industry Limited has evolved into a global leader in supplying chlorinated products to various sectors including Pharmaceuticals, Agrochemicals, and dyes. With extensive experience in chlorinated chemistry, the company offers a diverse range of intermediates and specialty chemicals catering to multiple applications across industries such as Textiles, Pharmaceuticals, Agrochemicals, and Advanced Polymers.
Over the years, TIL has significantly expanded its product portfolio, introducing pioneering chemicals like sodium hexameta phosphate, sodium tripoly phosphate, phosphoric acid, sodium hydrosulphite, and sodium formaldehyde sulphoxylate (safolite). It also became the first Indian manufacturer of products like thionyl chloride and sulphur dioxide, showcasing its commitment to innovation and excellence.
TIL’s global presence was established in 1987, earning recognition as a government-approved Export House. The company’s product range encompasses various chemicals and intermediates, including rubber accelerators and metals such as copper and zinc. Notably, TIL holds the distinction of being the world’s largest manufacturer of safolite and safolin, along with being India’s sole exporter of thionyl chloride and chloro acetyl chloride.
Throughout its history, TIL has continuously expanded its manufacturing capacities and explored strategic partnerships. Joint ventures in China for thionyl chloride production and capacity expansions for rubber chemicals and thionyl chloride underscore the company’s commitment to growth and innovation.
In recent years, TIL has focused on enhancing operational efficiency and technological advancements. Investments in improving manufacturing processes, such as debottlenecking and efficiency improvements, have resulted in increased production and cost savings. Furthermore, the company’s emphasis on research and development has led to the introduction of new products, strengthening its position in the market.
Company caters to a wide base of customers spread across more than 16 countries.
TIL’s growth trajectory has also been marked by strategic acquisitions and divestments. While acquiring a 50% stake in Sam Finechem Ltd. demonstrated its strategic expansion in the pharmaceutical sector, divestments from subsidiaries like Sam Fine O Chem Limited reflect the company’s focus on optimizing its portfolio for sustained growth.
Company’s products are manufactured at the Ekalbara Plant, situated 25 kilometers from the company’s headquarters in Vadodara. The company Dedicated multipurpose and multiproduct plants spread over 100 acres with total production capacity of 66,000 MTPA, supported by an expert team of engineers proficient in Process Scale-up, Plant Design, Erection, and Commissioning. Additionally, they offer contract manufacturing services and job work facilities, ensuring economically viable solutions for their customers.
They undertake projects for global clients across pharmaceuticals, agrochemicals, and specialty chemicals sectors, leveraging their expertise in chlorination technology and other core technologies.
Transpek’s R&D facility is integral to its growth, equipped with cutting-edge technology and equipment. Continuous research is conducted on new and existing products, focusing on enhancing manufacturing efficiency and developing competitive products like Acid Chlorides and Alkyl Chlorides. The facility includes gram lab, kilo lab, and pilot plant for process scaling. Operating under strict confidentiality with clients, the R&D team collaborates closely to bring innovative products to market. Recognized by the Department of Science & Technology, Government of India, and approved by Maharaja Sayajirao University of Vadodara for Ph.D. research, the facility underscores Transpek’s commitment to innovation and excellence.
TUV India Private Ltd has accredited Transpek with ISO 9001:2015, ISO 14001:2015, BS OHSAS 18001:2007 for Management System, and ISO 50001:2011 for Energy Management System. Company is also a signatory to the Global Responsible Care Initiative, and numerous of its initiatives are now being implemented.
In line with its commitment to innovation and expansion, TIL established Transpek Industry (Europe) Ltd. in the United Kingdom and incorporated Transpek Creative Chemistry Private Limited as a wholly-owned subsidiary, underscoring its global ambitions and commitment to future growth.
Business Products
In terms of usage by application company caters to the following Sectors
- AgroChemicals
- Pharmaceuticals
- Polymer
- Speciality Chemicals
- Surfactants
- Dyes
The sector of polymers, specialty plastics, and performance materials is experiencing rapid growth worldwide, driven by ongoing innovation and the trend of substituting metals with lightweight yet strong polymers. This global market is expected to continue expanding in the coming years. Transpek manufactures a diverse range of products supplied to numerous global companies in the polymer and specialty plastics manufacturing sector. Through long-term agreements, the company has substantially increased its production volumes and successfully stabilized operations. With operations now at desired capacity levels, the company anticipates stable volumes in both the short and long term.
Additionally, the company is actively developing new products, which, upon introduction, are expected to contribute positively to both the top and bottom lines of the company.
Capex
The capital expenditure (Capex) over the next two years will be determined by the timing of new product introductions, with any significant investments being announced accordingly. There are plans to replace an aging plant with a new one, boasting approximately 70% higher capacity. This strategic move aims to meet the anticipated increase in product demand. The new facility will be versatile, capable of producing multiple products to adapt to market dynamics. Commissioning of this multi-product plant is projected for January 2024.
Financials
For the year March 23
- In March 2023, the net sales totalled Rs. 827 crore, marking a increase of 38% compared to Rs. 599 crore in March 2022.
- Similarly, the net profit for March 2023 stood at Rs. 83 crore, representing a increase of 27% from Rs. 65 crore in March 2022.
- EBITDA for March 2023 was Rs. 151 crore, indicating a increase of 51% from Rs. 100 crore in March 2022.
- Furthermore, Transpek’s EPS increased to Rs. 149.46 in March 2023 from Rs. 117.09 in March 2022.
- Company has slowly increasing debt to fuel its capex. As seen over the past few years the debt has slowly increased from 111 crores to 145 crores.
- Company has a solid roce of 20% as seen from the Fy23.
- Besides that company has investments of 238 crores on the balance sheet as of FY23
- Cash and equivalents stood at 25 crores
For Q3FY24
- In December 2023, the net sales amounted to Rs. 148.32 crore, reflecting a decline of 24.51% compared to Rs. 196.47 crore recorded in December 2022.
- Similarly, the quarterly net profit for December 2023 stood at Rs. 14.08 crore, down by 43.05% from Rs. 24.72 crore in December 2022.
- EBITDA for December 2023 was Rs. 32.30 crore, indicating a decrease of 29.81% from Rs. 46.02 crore in December 2022.
- Furthermore, Transpek’s EPS decreased to Rs. 25.21 in December 2023 from Rs. 44.26 in December 2022.
Management’s comments
Since past few quarters management has not done any concall as a result more information about the company’s financials is not available.
Sectorial Outlook
The company has achieved record business volumes and profits, strengthening its financial position and paving the way for future growth. In the polymers and specialty plastics sector, the market remains consistent, with anticipated growth driven by increasing demand for high-strength, lightweight materials across industries such as automotive, defense, and construction. Continuous innovation in polymers contributes to steady market expansion, with the company poised to capitalize on this growth as a leading producer of Acid Chlorides. Additionally, in the pharmaceutical segment, the company maintains market share through long-standing relationships and a reputation for reliability and environmental, social, and governance (ESG) focus.
While product development in pharmaceuticals requires time, the company is committed to expanding its offerings. In other applications, such as Organic Peroxides and surfactants for personal care products, the company is gradually increasing volumes and market share. However, in the agrochemicals sector, where margins are under pressure due to price sensitivity, the company maintains a limited presence, focusing on other application segments for growth.
Note: Transpek industry has been suggested twice on darkhorsestocks.
Conclusion
Transpek, a 59-year-old company, specializes in manufacturing and exporting a diverse range of chemicals to industries such as Textiles, Pharmaceuticals, Agrochemicals, and Advanced Polymers. As a leading global supplier of Chlorinated Products, it caters to various sectors including Pharmaceuticals, Agrochemicals, and pigments. Despite achieving a Sales CAGR of 18% and a net profit CAGR of 26% over the past 5 years, the company’s stock hasn’t seen significant price appreciation relative to market trends. This discrepancy presents an opportunity for long-term exploration, given its consistent performance and potential for future growth. This is what makes it worth exploring.